Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Net Cash Flow: 2009-2025

Historic Net Cash Flow for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to -$16.0 million.

  • BIO-TECHNE's Net Cash Flow fell 152.28% to -$16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$48.2 million, marking a year-over-year decrease of 275.83%. This contributed to the annual value of -$1.5 million for FY2025, which is 94.21% up from last year.
  • According to the latest figures from Q3 2025, BIO-TECHNE's Net Cash Flow is -$16.0 million, which was down 296.37% from $8.2 million recorded in Q2 2025.
  • BIO-TECHNE's 5-year Net Cash Flow high stood at $54.4 million for Q2 2023, and its period low was -$46.9 million during Q1 2022.
  • For the 3-year period, BIO-TECHNE's Net Cash Flow averaged around -$2.7 million, with its median value being -$4.5 million (2024).
  • Per our database at Business Quant, BIO-TECHNE's Net Cash Flow skyrocketed by 232.24% in 2021 and then plummeted by 606.10% in 2023.
  • BIO-TECHNE's Net Cash Flow (Quarterly) stood at $12.4 million in 2021, then plummeted by 163.62% to -$7.9 million in 2022, then slumped by 177.20% to -$22.0 million in 2023, then spiked by 79.40% to -$4.5 million in 2024, then crashed by 152.28% to -$16.0 million in 2025.
  • Its last three reported values are -$16.0 million in Q3 2025, $8.2 million for Q2 2025, and -$35.8 million during Q1 2025.